• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动期间的动脉氧合在肺动脉高压中是否具有预后价值?

Does arterial oxygenation during exercise add prognostic value in pulmonary arterial hypertension?

作者信息

Alsina-Restoy Xavier, Torres-Castro Rodrigo, Torralba-García Yolanda, Burgos Felip, Barberà Joan Albert, Agustí Àlvar, Blanco Isabel

机构信息

Pulmonary Medicine Department, Respiratory Institute, Hospital Clinic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain.

Pulmonary Medicine Department, Respiratory Institute, Hospital Clinic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain; Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile.

出版信息

Respir Med. 2023 Jan;206:107070. doi: 10.1016/j.rmed.2022.107070. Epub 2022 Dec 5.

DOI:10.1016/j.rmed.2022.107070
PMID:36508987
Abstract

BACKGROUND

The 6-min walking distance (6MWD) is often used to assess prognosis in pulmonary arterial hypertension (PAH) patients. Whether or not changes in arterial oxygen saturation (SpO) during exercise add prognostic value to the 6MWD in these patients is unclear. The objective of this study was to investigate if SpO changes during exercise adds prognostic value to the 6MWD in PAH patients.

METHODS

Ambispective study that includes 137 patients with PAH: 38 idiopathic/heritable (i/h PAH), 42 with connective tissue disease (CTD-PAH), 34 with porto-pulmonary hypertension (PoPH), 21 with HIV-associated PAH and 2 with pulmonary venous occlusive disease (PVOD). Patients were characterized and, treated according to international recommendations, and were followed-up for 5 years. To integrate SpO changes during exercise, we calculated the desaturation distance ratio (DDR) either in its original form (from a maximal theoretical value of 100%) or the actual resting SpO value of the patient (new DDR) as well as the distance saturation product (DSP).

RESULTS

(1) during follow-up, 40 patients died (29.2%); (2) results confirmed the prognostic value of the 6MWD (AUC 0.913 [IQR 0.868-0.958]; p < 0.0001), original DDR (AUC 0.923 [0.881-0.966]; p < 0.001), New DDR (AUC 0.917 [0.872-0.961], p < 0.001), and DSP (AUC 0.914 [0.869-0.959], p < 0.001); and, (3) neither the original or new DDR or DSP added significant prognostic value to 6MWD in these patients.

CONCLUSIONS

Consideration of three different composite indices of arterial oxygenation changes during exercise does not add prognostic value to that of the 6MWD in patients with PAH.

摘要

背景

6分钟步行距离(6MWD)常用于评估肺动脉高压(PAH)患者的预后。运动期间动脉血氧饱和度(SpO)的变化是否能为这些患者的6MWD增加预后价值尚不清楚。本研究的目的是调查运动期间SpO变化是否能为PAH患者的6MWD增加预后价值。

方法

前瞻性研究纳入137例PAH患者:38例特发性/遗传性(i/h PAH),42例结缔组织病相关(CTD-PAH),34例门脉性肺动脉高压(PoPH),21例HIV相关PAH,2例肺静脉闭塞性疾病(PVOD)。对患者进行特征分析,并根据国际指南进行治疗,随访5年。为纳入运动期间SpO的变化,我们计算了去饱和距离比(DDR),其原始形式(基于100%的最大理论值)或患者的实际静息SpO值(新DDR)以及距离饱和度乘积(DSP)。

结果

(1)随访期间,40例患者死亡(29.2%);(2)结果证实了6MWD(AUC 0.913[IQR 0.868 - 0.958];p < 0.0001)、原始DDR(AUC 0.923[0.881 - 0.966];p < 0.001)、新DDR(AUC 0.917[0.872 - 0.961],p < 0.001)和DSP(AUC 0.914[0.869 - 0.959],p < 0.001)的预后价值;(3)在这些患者中,原始或新的DDR或DSP均未为6MWD增加显著的预后价值。

结论

考虑运动期间动脉氧合变化的三种不同综合指标并未为PAH患者的6MWD增加预后价值。

相似文献

1
Does arterial oxygenation during exercise add prognostic value in pulmonary arterial hypertension?运动期间的动脉氧合在肺动脉高压中是否具有预后价值?
Respir Med. 2023 Jan;206:107070. doi: 10.1016/j.rmed.2022.107070. Epub 2022 Dec 5.
2
Evaluation of novel indices of walking performance taking oxygen desaturation into account during six-minute walk test in cardiovascular disease patients.评估心血管疾病患者在六分钟步行试验中考虑氧饱和度降低时的新型行走能力指标。
Heart Vessels. 2024 Oct;39(10):877-883. doi: 10.1007/s00380-024-02411-8. Epub 2024 May 12.
3
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.COMPERA 分析:肺动脉高压试验中改善终点的预后价值。
J Heart Lung Transplant. 2022 Jul;41(7):971-981. doi: 10.1016/j.healun.2022.03.011. Epub 2022 Mar 22.
4
Prognostic relevance of changes in exercise test variables in pulmonary arterial hypertension.运动试验变量变化对肺动脉高压的预后意义。
PLoS One. 2013 Sep 5;8(9):e72013. doi: 10.1371/journal.pone.0072013. eCollection 2013.
5
Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.超声心动图、6 分钟步行距离和距离饱和度乘积预测特发性肺纤维化中的肺动脉高压。
Respir Care. 2010 May;55(5):584-8.
6
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial.安立生坦在结缔组织病相关肺动脉高压(CTD-PAH)中的反应——ARIES-E临床试验的亚组分析。
Respir Med. 2016 Aug;117:254-63. doi: 10.1016/j.rmed.2016.06.018. Epub 2016 Jun 29.
7
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).与甲基苯丙胺相关的肺动脉高压:来自全国肺动脉高压生物样本和数据资源库(PAH Biobank)的数据。
BMJ Open Respir Res. 2023 Dec 7;10(1):e001917. doi: 10.1136/bmjresp-2023-001917.
8
[Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].[心肺运动试验在比较三种肺动脉高压患者心肺功能中的价值]
Zhonghua Yi Xue Za Zhi. 2015 Nov 24;95(44):3598-601.
9
[Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].[先天性心脏病相关肺动脉高压患者不同亚型的死亡危险因素及临床特征]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):315-322. doi: 10.3760/cma.j.cn112148-20190628-00364.
10
Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.长期口服波生坦治疗不同类型肺动脉高压的疗效和安全性:系统评价和荟萃分析。
Am J Cardiovasc Drugs. 2021 Mar;21(2):181-191. doi: 10.1007/s40256-020-00426-w.

引用本文的文献

1
Assessment of Exercise Capacity in Post-COVID-19 Patients: How Is the Appropriate Test Chosen?新冠后患者运动能力评估:如何选择合适的测试?
Life (Basel). 2023 Feb 23;13(3):621. doi: 10.3390/life13030621.